These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 24448899)
1. Metabolic syndrome in patients taking clozapine: prevalence and influence of catechol-O-methyltransferase genotype. Zhang Y; Chen M; Chen J; Wu Z; Yu S; Fang Y; Zhang C Psychopharmacology (Berl); 2014 May; 231(10):2211-8. PubMed ID: 24448899 [TBL] [Abstract][Full Text] [Related]
2. Complement 3 and metabolic syndrome induced by clozapine: a cross-sectional study and retrospective cohort analysis. Zhang C; Zhang Y; Cai J; Chen M; Song L Pharmacogenomics J; 2017 Jan; 17(1):92-97. PubMed ID: 26503818 [TBL] [Abstract][Full Text] [Related]
3. Association study of Val66Met polymorphism in brain-derived neurotrophic factor gene with clozapine-induced metabolic syndrome: preliminary results. Zhang Y; Chen M; Wu Z; Chen J; Yu S; Fang Y; Zhang C PLoS One; 2013; 8(8):e72652. PubMed ID: 23967328 [TBL] [Abstract][Full Text] [Related]
4. Catechol-O-methyltransferase rs4680 and rs4818 haplotype association with treatment response to olanzapine in patients with schizophrenia. Nikolac Perkovic M; Sagud M; Zivkovic M; Uzun S; Nedic Erjavec G; Kozumplik O; Svob Strac D; Mimica N; Mihaljevic Peles A; Pivac N Sci Rep; 2020 Jun; 10(1):10049. PubMed ID: 32572118 [TBL] [Abstract][Full Text] [Related]
5. Association between SCAP and SREBF1 gene polymorphisms and metabolic syndrome in schizophrenia patients treated with atypical antipsychotics. Yang L; Chen J; Li Y; Wang Y; Liang S; Shi Y; Shi S; Xu Y World J Biol Psychiatry; 2016 Sep; 17(6):467-74. PubMed ID: 26982812 [TBL] [Abstract][Full Text] [Related]
6. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia. Woodward ND; Jayathilake K; Meltzer HY Schizophr Res; 2007 Feb; 90(1-3):86-96. PubMed ID: 17123785 [TBL] [Abstract][Full Text] [Related]
7. Latent Toxoplasma gondii infection is associated with decreased serum triglyceride to high-density lipoprotein cholesterol ratio in male patients with schizophrenia. Sagud M; Vlatkovic S; Svob Strac D; Sviben M; Zivkovic M; Vilibic M; Vuksan-Cusa B; Mihaljevic-Peles A; Pivac N Compr Psychiatry; 2018 Apr; 82():115-120. PubMed ID: 29477703 [TBL] [Abstract][Full Text] [Related]
8. Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics. Bai YM; Chen TT; Liou YJ; Hong CJ; Tsai SJ Schizophr Res; 2011 Feb; 125(2-3):179-86. PubMed ID: 21185157 [TBL] [Abstract][Full Text] [Related]
9. Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment. Chen CY; Yeh YW; Kuo SC; Ho PS; Liang CS; Yen CH; Lu RB; Huang SY Psychoneuroendocrinology; 2016 Mar; 65():67-75. PubMed ID: 26724569 [TBL] [Abstract][Full Text] [Related]
10. Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment. Gupta M; Bhatnagar P; Grover S; Kaur H; Baghel R; Bhasin Y; Chauhan C; Verma B; Manduva V; Mukherjee O; Purushottam M; Sharma A; Jain S; Brahmachari SK; Kukreti R Pharmacogenomics; 2009 Mar; 10(3):385-97. PubMed ID: 19290789 [TBL] [Abstract][Full Text] [Related]
11. Differing Prevalence and Correlates of Metabolic Syndromes Between Chlorpromazine and Clozapine: A 10-year Retrospective Study of a Male Chinese Cohort. Xing M; Sheng J; Cui M; Su Y; Zhang C; Chen X; Fang Y; Cui D; Li Z Curr Neuropharmacol; 2022; 20(10):1969-1977. PubMed ID: 35236263 [TBL] [Abstract][Full Text] [Related]
12. The relationship between brain-derived neurotrophic factor and metabolic syndrome in patients with chronic schizophrenia: A systematic review. Kalejahi P; Kheirouri S; Noorazar SG; Sanayei M Neuropeptides; 2021 Jun; 87():102135. PubMed ID: 33812160 [TBL] [Abstract][Full Text] [Related]
13. The relationship between serum adiponectin levels, cardiometabolic indices and metabolic syndrome in schizophrenia. Tay YH; Lee J Asian J Psychiatr; 2019 Jun; 43():1-6. PubMed ID: 31059867 [TBL] [Abstract][Full Text] [Related]
14. COMT Val158Met and 5-HT1A-R -1019 C/G polymorphisms: effects on the negative symptom response to clozapine. Bosia M; Lorenzi C; Pirovano A; Guglielmino C; Cocchi F; Spangaro M; Bramanti P; Smeraldi E; Cavallaro R Pharmacogenomics; 2015 Jan; 16(1):35-44. PubMed ID: 25560469 [TBL] [Abstract][Full Text] [Related]
15. Does antipsychotic polypharmacy increase the risk for metabolic syndrome? Correll CU; Frederickson AM; Kane JM; Manu P Schizophr Res; 2007 Jan; 89(1-3):91-100. PubMed ID: 17070017 [TBL] [Abstract][Full Text] [Related]
16. Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics. Ellingrod VL; Taylor SF; Dalack G; Grove TB; Bly MJ; Brook RD; Zöllner SK; Pop-Busui R J Clin Psychopharmacol; 2012 Apr; 32(2):261-5. PubMed ID: 22370993 [TBL] [Abstract][Full Text] [Related]
17. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study. Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207 [TBL] [Abstract][Full Text] [Related]
18. The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia. Lee NY; Roh MS; Kim SH; Jung DC; Yu HY; Sung KH; Chung IW; Youn T; Kang UG; Ahn YM; Kim YS Int Clin Psychopharmacol; 2013 Mar; 28(2):71-9. PubMed ID: 23211493 [TBL] [Abstract][Full Text] [Related]
19. Effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia. Wu RR; Zhao JP; Liu ZN; Zhai JG; Guo XF; Guo WB; Tang JS Psychopharmacology (Berl); 2006 Jul; 186(4):572-8. PubMed ID: 16601995 [TBL] [Abstract][Full Text] [Related]
20. Association between SREBF2 gene polymorphisms and metabolic syndrome in clozapine-treated patients with schizophrenia. Yang L; Chen J; Liu D; Yu S; Cong E; Li Y; Wu H; Yue Y; Zuo S; Wang Y; Liang S; Shi Y; Shi S; Xu Y Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():136-41. PubMed ID: 25201120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]